Skip to main content

Healing Words: Using Affect Labeling to Reduce the Effects of Unpleasant Cues on Symptom Reporting in IBS Patients

Abstract

Purpose

The present study aimed to induce elevated symptom reports through the presentation of unpleasant cues in patients with irritable bowel syndrome (IBS) and examine whether applying an emotion regulation technique (affect labeling) can reduce symptom reporting in patients.

Methods

Patients diagnosed with IBS (N = 29) and healthy controls (N = 26) were presented with six picture series (three pleasant, three unpleasant) under three within-subject conditions: merely viewing, emotional labeling, or content (non-emotional) labeling. Each picture viewing trial was followed by affect ratings and a symptom checklist, consisting of general arousal and IBS-specific symptoms.

Results

Viewing unpleasant pictures led to overall increased symptom reports, both for arousal and gastrointestinal symptoms, in both groups. Labeling the pictures did not reduce these effects significantly, although a trend toward less arousal symptoms after unpleasant cues emerged in the patient group only, especially during emotional labeling.

Conclusions

Current findings indicate that the mere presentation of unpleasant cues can induce elevated symptom reports in IBS patients. The results of the labeling manipulation provide modest support for the effectiveness of emotion regulation strategies in reversing these effects of unpleasant cues in patients suffering from functional syndromes. Methodological issues that may have confounded present results are discussed.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

Notes

  1. 1.

    Positive 1: 1463, 1920, 2550, 4574, 5201, 5260, 7330, 8030, 8080, 8185; positive 2: 1620, 2341, 5700, 5760, 5849, 7280, 8200, 8370, 8461, 8490; Positive 3: 1710, 2311, 2360, 5891, 7260, 8033, 8190, 8300, 8470, 8502; negative 1: 1114, 2095, 2520, 2692, 2900.1, 5971, 6315, 6821, 9181, 9611; negative 2: 1525, 6190, 6242, 9001, 9410, 9425, 9426, 9520, 9561, 9911; negative 3: 1932, 2800, 5972, 6300, 6370, 6800, 6838, 9041, 9140, 9421.

  2. 2.

    Positive pleasantness ratings (1–9): M1 = 7.50 SD1 = 0.36, M2 = 7.57 SD2 = 0.46, M3 = 7.55 SD3 = 0.60; positive arousal ratings (1–9): M1 = 5.39 SD1 = 1.30, M2 = 5.09 SD2 = 1.27, M3 = 5.14 SD3 = 1.09; negative pleasantness ratings (1–9): M1 = 2.72 SD1 = 0.79, M2 = 2.58 SD2 = 0.65, M3 = 2.72 SD3 = 0.71; negative arousal ratings (1–9): M1 = 5.80 SD1 = 0.77, M2 = 5.71 SD2 = 1.02, M3 = 5.77 SD3 = 0.75.

  3. 3.

    A parallel analysis procedure [36] was first conducted to determine the number of reliable factors, which suggested a two-factor structure for the checklist. A principal component analysis (PCA) with varimax rotation and factor extraction constrained to two factors (KMO = .57; χ2 (91) = 242.61, p < .001) confirmed the two-factor structure, which could explain 37.91 % of the variance. Items loading .60 or higher were retained for each of the two factors.

References

  1. 1.

    Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011;52(3):263–71.

    Article  PubMed  Google Scholar 

  2. 2.

    Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric co‐morbidity and management. Int J Methods Psychiatr Res. 2003;12(1):34–43.

    Article  PubMed  Google Scholar 

  3. 3.

    Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res. 2001;51:361–7.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Reid S, Wessely S, Crayford T, Hotopf M. Medically unexplained symptoms in frequent attenders of secondary health care: retrospective cohort study. Brit Med J. 2001;322:1–4.

    Article  Google Scholar 

  5. 5.

    Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354:936–9.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528–33.

    Article  PubMed  Google Scholar 

  7. 7.

    Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30(3):191–9.

    Article  PubMed  Google Scholar 

  8. 8.

    De Waal MW, Arnold IA, Eekhof JA, Van Hemert AM. Somatoform disorders in general practice prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Brit J Psychiatry. 2004;184(6):470–6.

    Article  Google Scholar 

  9. 9.

    Montoya P, Sitges C, García-Herrera M, Izquierdo R, Truyols M, Blay N, et al. Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia. Psychosom Med. 2005;67:957–63.

    Article  PubMed  Google Scholar 

  10. 10.

    Dickhaus B, Mayer EA, Firooz N, Stains J, Conde F, Olivas TI, et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol. 2003;98:135–43.

    Article  PubMed  Google Scholar 

  11. 11.

    Murray CD, Flynn J, Ratcliffe L, Jacyna MR, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology. 2004;127(6):1695–703.

    Article  PubMed  Google Scholar 

  12. 12.

    Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36(1):310–40.

    Article  PubMed  Google Scholar 

  13. 13.

    Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280(4):519–24.

    Google Scholar 

  14. 14.

    Naliboff BD, Waters AM, Labus JS, Kilpatrick L, Craske MG, et al. Increased acoustic startle responses in IBS patients during abdominal and nonabdominal threat. Psychosom Med. 2008;70(8):920–7.

    PubMed Central  Article  PubMed  Google Scholar 

  15. 15.

    Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology. 2011;140(1):91–100.

    PubMed Central  Article  PubMed  Google Scholar 

  16. 16.

    Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Ohning G, et al. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci. 2008;28(2):349–59.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain. 2005;115:398–409.

    Article  PubMed  Google Scholar 

  18. 18.

    Bogaerts K, Janssens T, de Peuter S, Van Diest I, Van den Bergh O. Negative affective pictures can elicit physical symptoms in high habitual symptom reporters. Psychol Health. 2010;25(6):685–98.

    Article  PubMed  Google Scholar 

  19. 19.

    Constantinou E, Bogaerts K, Van Diest I, Van den Bergh O. Inducing symptoms in high symptom reporters via emotional pictures: the interactive effects of valence and arousal. J Psychosom Res. 2013;74(3):191–6.

    Article  PubMed  Google Scholar 

  20. 20.

    Elsenbruch S, Rosenberger C, Bingel U, Forsting M, Schedlowski M, Gizewski ER. Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology. 2010;139(4):1310–9.

    Article  PubMed  Google Scholar 

  21. 21.

    van Middendorp H, Lumley MA, Jacobs JWG, van Doornen LJP, Bijlsma JWJ, Geenen R. Emotions and emotional approach and avoidance strategies in fibromyalgia. J Psychosom Res. 2008;64:159–67.

    Article  PubMed  Google Scholar 

  22. 22.

    Solberg Nes L, Roach AR, Segerstrom SC. Executive functions, self-regulation, and chronic pain: a review. Ann Behav Med. 2009;37(2):173–83.

    Article  PubMed  Google Scholar 

  23. 23.

    Berkman ET, Lieberman MD. Using neuroscience to broaden emotion regulation: theoretical and methodological considerations. Soc Personal Psychol Compass. 2009;3:475–93.

    PubMed Central  Article  PubMed  Google Scholar 

  24. 24.

    Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JDE, et al. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. NeuroImage. 2004;23:483–99.

    Article  PubMed  Google Scholar 

  25. 25.

    Hariri AR, Bookheimer SY, Mazziotta JC. Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport. 2000;11(1):43–8.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Lieberman MD, Eisenberger NI, Crockett MJ, Tom SM, Pfeifer JH, Way BM. Putting feelings into words: affect labeling disrupts amygdala activity in response to affective stimuli. Psychol Sci. 2007;18(5):421–8.

    Article  PubMed  Google Scholar 

  27. 27.

    Lieberman MD, Inagaki TK, Tabibnia G, Crockett MJ. Subjective responses to emotional stimuli during labeling, reappraisal, and distraction. Emotion. 2011;11(3):468–80.

    PubMed Central  Article  PubMed  Google Scholar 

  28. 28.

    Kircanski K, Lieberman MD, Craske MG. Feelings into words: contributions of language to exposure therapy. Psychol Sci. 2012;23(10):1086–91.

    Article  PubMed  Google Scholar 

  29. 29.

    Barrett LF. Solving the emotion paradox: categorization and the experience of emotion. Pers Soc Psychol Rev. 2006;10(1):20–46.

    Article  PubMed  Google Scholar 

  30. 30.

    Lieberman MD. Why symbolic processing of affect can disrupt negative affect: social cognitive and affective neuroscience investigations. In: Todorov A, Fiske S, Prentice D, editors. Social neuroscience: toward understanding the underpinnings of the social mind. New York: Oxford University Press; 2011. p. 188–209.

    Chapter  Google Scholar 

  31. 31.

    Constantinou E, Van den Houte M, Bogaerts K, Van Diest I, Van den Bergh O. Can words heal? Using affect labeling to reduce the effects of unpleasant cues on symptom reporting. Front Psychol. 2014;5:807. doi:10.3389/fpsyg.2014.00807.

    PubMed Central  Article  PubMed  Google Scholar 

  32. 32.

    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 suppl 2:II43–7.

    PubMed Central  PubMed  Google Scholar 

  33. 33.

    Lang PJ, Bradley MM, Cuthbert B. International affective picture system (IAPS): instruction manual and affective ratings. Technical report A-6. Gainesville: University of Florida; 2005.

    Google Scholar 

  34. 34.

    Mikels JA, Fredrickson BL, Larkin GR, Lindberg CM, Maglio SJ, Reuter-Lorenz PA. Emotional category data on images from the international affective picture system. Behav Res Methods. 2005;37:626–30.

    PubMed Central  Article  PubMed  Google Scholar 

  35. 35.

    Bradley MM, Lang PJ. Measuring emotion: the self-assessment manikin and the semantic differential. J Behav Ther Exp Psychiatry. 1994;25:49–59.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30(2):179–85.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Wientjes CJ, Grossman P. Over-reactivity of the psyche or the soma? Interindividual associations between psychosomatic symptoms, anxiety, heart rate, and end-tidal partial carbon dioxide pressure. Psychosom Med. 1994;56:533–40.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Spinhoven PH, Ormel J, Sloekers PPA, Kempen GIJM, Speckens AEM, Hemert AV. A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–70.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Spruyt A, Clarysse J, Vansteenwegen D, Baeyens F, Hermans D. Affect 4.0: a free software package for implementing psychological and psychophysiological experiments. Exp Psychol. 2010;57:36–45.

    Article  PubMed  Google Scholar 

  41. 41.

    Crane C, Martin M. Illness schema and level of reported gastrointestinal symptoms in irritable bowel syndrome. Cogn Ther Res. 2003;27(2):185–203.

    Article  Google Scholar 

  42. 42.

    Keefe FJ, Lumley M, Anderson T, Lynch T, Carson KL. Pain and emotion: new research directions. J Clin Psychol. 2001;57(4):587–607.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Porcelli P, Taylor GJ, Bagby RM, De Carne M. Alexithymia and functional gastrointestinal disorders. Psychother Psychosom. 1999;68(5):263–9.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Halpert A, Rybin D, Doros G. Expressive writing is a promising therapeutic modality for the management of IBS: a pilot study. Am J Gastroenterol. 2010;105:2440–8.

    Article  PubMed  Google Scholar 

  45. 45.

    Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol. 2011;106(9):1678–88.

    Article  PubMed  Google Scholar 

  46. 46.

    Ljótsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Rück C, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome—a randomized controlled trial. Behav Res Ther. 2010;48(6):531–9.

    Article  PubMed  Google Scholar 

  47. 47.

    Zernicke KA, Campbell TS, Blustein PK, Fung TS, Johnson JA, Bacon SL, et al. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med. 2013;20(3):385–96.

    Article  PubMed  Google Scholar 

  48. 48.

    Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16(4):266–75.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  49. 49.

    McTeague LM, Lang PJ. The anxiety spectrum and the reflex physiology of defense: from circumscribed fear to broad distress. Depress Anxiety. 2012;29(4):264–81.

    PubMed Central  Article  PubMed  Google Scholar 

Download references

Acknowledgments

Authors would like to thank the physicians and clinical trial coordinators at the gastrointestinal unit of the University Hospital Gasthuisberg (Leuven, Belgium) for the recruitment of IBS patients and Stéphanie Vandeweyer for her assistance in data collection.

Compliance with Ethical Standards

Each of the following authors, Elena Constantinou, Katleen Bogaerts, Lukas Van Oudenhove, Jan Tack, Ilse Van Diest, and Omer Van den Bergh, declares that s/he has no conflict of interest, that all procedures performed in this study were in accordance with the ethical standards of both the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards, and that informed consent was obtained from all individual participants included in the study.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Omer Van den Bergh.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Constantinou, E., Bogaerts, K., Van Oudenhove, L. et al. Healing Words: Using Affect Labeling to Reduce the Effects of Unpleasant Cues on Symptom Reporting in IBS Patients. Int.J. Behav. Med. 22, 512–520 (2015). https://doi.org/10.1007/s12529-014-9449-8

Download citation

Keywords

  • Emotion regulation
  • Affect labeling
  • Symptom reporting
  • IBS patients